GP2 and cancer: In this study, we aimed at developing a liposomal vaccine composed of DMPC- DMPG- Chol- DOPE containing MPL with Gp2 peptide conjugated to the surface of liposomes to increase the CTL response and cellular immunity in the BALB/c mice model of TUBO xenograft cancer.